CompletedPHASE2, PHASE3NCT00685230
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Studying Scorpion envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Principal Investigator
- Leslie Boyer, MDPoison and Drug Center
- Intervention
- Antivenin Centruroides (scorpion) equine immune F(ab)2(biological)
- Enrollment
- 15 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2005
Study locations (2)
- Tucson Medical Center, Tucson, Arizona, United States
- University Medical Center, Tucson, Arizona, United States
Collaborators
University of Arizona · Universidad Nacional Autonoma de Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00685230 on ClinicalTrials.gov